Sunday, November 21, 2021

New Zantrene Cancer Drug protects the heart from death

Australian biotech and precision oncology company, Race Oncology, has announced breakthrough preclinical research that has found its drug Zantrene® is able to protect heart muscle cells from death while improving the killing of breast cancer cells when used in combination with the anthracycline, doxorubicin. - eTurboNews | Trends | Travel News

No comments:

Post a Comment